Get startedLog in
    Picture of Quantum Genomics SA logo

    ALQGC — Quantum Genomics SA News Story

    0.000.00%
    fr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    All News

    Brief: Quantum Genomics announces design of its next phase II trial in arterial hypertension

    Picture of Quantum Genomics SA logoQuantum Genomics SA
    28/06/2017 06:31
    June 28 (Reuters) - QUANTUM GENOMICS SA  ALQGC.PA : 
    * QUANTUM GENOMICS ANNOUNCES THE DESIGN OF ITS NEXT PHASE II 
TRIAL IN ARTERIAL HYPERTENSION, NEW-HOPE 
    * AT END OF THIS TRIAL - RESULTS OF WHICH ARE EXPECTED IN 
FIRST HALF OF 2019 - A PHASE III CLINICAL TRIAL COULD THEN BE 
INITIATED WITH QGC001. 
 
SOURCE TEXT FOR EIKON:  ID:nACT49194  
FURTHER COMPANY COVERAGE:  ALQGC.PA  
 
 (Gdynia Newsroom:) 
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))

    Recent news on Quantum Genomics SA

    See all news